Quay lại
Giá NovaBay Pharmaceuticals Inc (NBY)
Biểu đồ giá cổ phiếu NBY
NBY Thu nhập
NovaBay Pharmaceuticals Inc
$14.77
16.39%
$2.08
Khi đóng cửa: Jan 16, 16:00:00 GMT-5
$12.91
-12.59%
$-1.85
Phiên sau giờ: Jan 16, 20:00:00 GMT-5
Thống kê chính
Giá đóng cửa trước
$12.69
Giá mở cửa
$12.3
Phạm vi ngày
$11.91 - $18.4
Phạm vi 52 tuần
$0.46 - $19.95
Khối lượng
2.7M
Khối lượng trung bình
1.2M
EPS (TTM)
-6.62
Tỷ suất cổ tức
--
Vốn hóa thị trường
$1.6B
NBY là gì?
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved